Oseltamivir (Tamiflu) Induced Depressive Episode in a Female Adolescent

Article

关键词: NEUROPSYCHIATRIC ADVERSE EVENTS;    INFLUENZA;    CHILDREN;    METABOLITE;    SAFETY;   

DOI  :  10.4306/pi.2010.7.4.302

来源: SCIE

【 摘 要 】

Oseltamivir was developed for prophylactic and therapeutic use against influenza, specifically targeting the viral enzyme's highly-conserved active site. In recent years, there have been case reports of neuropsychiatric events during or after oseltamivir treatment, in Japan, and other countries. However, a search of the literature revealed no such cases in South Korea. We present the case of a 15-year-old female adolescent diagnosed with depressive episode after taking oseltamivir. Oseltamivir is generally well tolerated. Its most frequent adverse effects include nausea and vomiting, diarrhea, and abdominal pain. In influenza patients taking oseltamivir, neuropsychiatric adverse events include delirium, behavioral disturbance, suicide, delusion, panic attack, convulsion, depressed mood, loss of consciousness, etc. Reportedly, such neuropsychiatric adverse events were more common in children than in adults and generally occurred within 48 hours of administration. Here, we report a retrospective review case of an oseltamivir-related neuropsychiatric event in a female adolescent in South Korea. Psychiatry Investig 2010;7:302-304

【 授权许可】

Free